In an exciting move, Pfizer and Cipla have agreed to charge minimal costs for 16 common chemotherapy drugs in Ethiopia, Nigeria, Kenya, Uganda, Rwanda and Tanzania. Prices are estimated to be just above their manufacturing costs ensuring affordable treatment to tens of thousands. In addition to reduced drug costs, IBM programmers will translate simplified treatment guidelines in to online tools which can be accessed by any country oncologist with an internet connection. To read more on the NYT article click here

To learn more about the original press release, click here